Understanding risks and outcomes of blood clots in young patients
Mentorship in Investigating Novel Risk Models and Prognostic Factors in Patients Less Than 21 Years Old with Venous Thromboembolism
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-11036368
This study is looking at blood clots in young people under 21 to find better ways to predict how they will do and improve their treatment, all while helping new researchers learn more about this important health issue.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11036368 on ClinicalTrials.gov |
What this research studies
This research focuses on venous thromboembolism (VTE), a condition where blood clots form in veins, affecting patients under 21 years old. The study aims to develop and validate specific risk assessment models and identify prognostic factors that can help predict outcomes for these young patients. By mentoring junior researchers, the project seeks to enhance knowledge and improve treatment strategies for VTE, which can lead to serious complications like chronic venous insufficiency. The approach includes analyzing existing data and collaborating with international experts to fill critical knowledge gaps in this area.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients under 21 years old who have experienced venous thromboembolism or are at risk for developing this condition.
Not a fit: Patients over 21 years old or those without a history of venous thromboembolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for blood clots in young patients, ultimately improving their health outcomes.
How similar studies have performed: Previous research has shown success in developing risk assessment models for pediatric VTE, indicating that this approach has potential for further advancements.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GOLDENBERG, NEIL A — JOHNS HOPKINS UNIVERSITY
- Study coordinator: GOLDENBERG, NEIL A
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acute respiratory infection